What is the future of ocular lubricants in dry eye treatment?

8 May 2019
Spring 2019

Léa Surugue looks at the dynamic expansion of next-generation artificial tears, and asks what other tailored products are emerging.

The TFOS DEWS II report of 2017 established the idea that dry eye disease (DED) is a multifactorial disorder. Manifesting itself with varying degrees of severity, DED requires a variety of treatment approaches. Research has been moving along quickly to discover new products that can best address this complexity, while recognising the difficulty of finding a universal treatment for all. 

Until now, traditional ocular lubricants have tended to offer patients only a palliative approach to dry eye symptom management, without necessarily trying to resolve the causes of the disorder. 

Jennifer Craig FCOptom, Vice-Chair and one of the lead authors of the TFOS DEWS II report, explains: “New lubricants are working harder than ever to address the different reasons people have dry eyes, which often requires complex combinations of features within the drops. 

Sign in to continue

Forgotten password?
Register

Not already a member of the College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

The standardisation of digital imaging across eye care services will transform efficiencies, accessibility and timely care of patients.

The College has offered its congratulations to Sir Keir Starmer and the Labour Party on their success in the General Election and on forming the next UK government.

The College of Optometrists is calling on the next Westminster government to establish optometrists as the first port of call for anyone with an eye care issue.